Navamedic ASA (OSL:NAVA)

Norway flag Norway · Delayed Price · Currency is NOK
20.50
-0.20 (-0.97%)
Mar 6, 2026, 3:22 PM CET
3.02%
Market Cap 491.62M
Revenue (ttm) 565.36M
Net Income (ttm) -23.54M
Shares Out 23.98M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9,170
Average Volume 307,840
Open 20.70
Previous Close 20.70
Day's Range 20.20 - 20.70
52-Week Range 17.10 - 27.90
Beta 0.15
RSI 38.18
Earnings Date Feb 12, 2026

About Navamedic ASA

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company’s product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propioni... [Read more]

Sector Healthcare
Founded 2002
Employees 42
Stock Exchange Oslo Børs
Ticker Symbol NAVA
Full Company Profile

Financial Performance

In 2025, Navamedic ASA's revenue was 565.36 million, an increase of 6.38% compared to the previous year's 531.44 million. Losses were -23.54 million, 329.1% more than in 2024.

Financial Statements

News

Navamedic ASA (OSL:NAVA) Q4 2025 Earnings Report Preview: What To Look For

Navamedic ASA (OSL:NAVA) Q4 2025 Earnings Report Preview: What To Look For

23 days ago - GuruFocus